+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

Chemotherapy Induced Anemia - Pipeline Insight, 2024 - Product Thumbnail Image

Chemotherapy Induced Anemia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Waldenstrom Macroglobulinemia - Pipeline Insight, 2024 - Product Thumbnail Image

Waldenstrom Macroglobulinemia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Gallbladder Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Gallbladder Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Hairy Cell Leukemia - Pipeline Insight, 2024 - Product Thumbnail Image

Hairy Cell Leukemia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Anaplastic astrocytoma - Pipeline Insight, 2024 - Product Thumbnail Image

Anaplastic astrocytoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 85 Pages
  • Global
From
Ewing Sarcoma - Pipeline Insight, 2024 - Product Thumbnail Image

Ewing Sarcoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 115 Pages
  • Global
From
Anaplastic Large Cell Lymphoma - Pipeline Insight, 2024 - Product Thumbnail Image

Anaplastic Large Cell Lymphoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Anti-CD20 antibody - Pipeline Insight, 2024 - Product Thumbnail Image

Anti-CD20 antibody - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Recurrent anaplastic astrocytomas - Pipeline Insight, 2024 - Product Thumbnail Image

Recurrent anaplastic astrocytomas - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Glioblastoma - Pipeline Insight, 2024 - Product Thumbnail Image

Glioblastoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 440 Pages
  • Global
From
Gastric Neuroendocrine Tumors - Pipeline Insight, 2024 - Product Thumbnail Image

Gastric Neuroendocrine Tumors - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
TCR-Therapy - Pipeline Insight, 2024 - Product Thumbnail Image

TCR-Therapy - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 190 Pages
  • Global
From
HER2-positive Gastric Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

HER2-positive Gastric Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 80 Pages
  • Global
From
T-cell Acute Lymphoblastic Leukemia - Pipeline Insight, 2024 - Product Thumbnail Image

T-cell Acute Lymphoblastic Leukemia - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 50 Pages
  • Global
From
From
Lung Adenocarcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Lung Adenocarcinoma - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 90 Pages
  • Global
From
Head and Neck Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Head and Neck Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 230 Pages
  • Global
From
From
PD-1 Non-Small Cell Lung Cancer (PD-1+ NSCLC) - Pipeline Insight, 2024 - Product Thumbnail Image

PD-1 Non-Small Cell Lung Cancer (PD-1+ NSCLC) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Follicular Lymphoma - Pipeline Insight, 2024 - Product Thumbnail Image

Follicular Lymphoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 180 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more